- Home
- ZURA vs BDL Comparison
ZURA vs BDL Comparison
Compare ZURA & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- BDL
- Stock Information
- Founded
- ZURA 2022
- BDL 1959
- Country
- ZURA United States
- BDL United States
- Employees
- ZURA N/A
- BDL N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- BDL Restaurants
- Sector
- ZURA Health Care
- BDL Consumer Discretionary
- Exchange
- ZURA Nasdaq
- BDL Nasdaq
- Market Cap
- ZURA 69.9M
- BDL 57.7M
- IPO Year
- ZURA N/A
- BDL N/A
- Fundamental
- Price
- ZURA $2.04
- BDL $28.79
- Analyst Decision
- ZURA Buy
- BDL
- Analyst Count
- ZURA 10
- BDL 0
- Target Price
- ZURA $12.67
- BDL N/A
- AVG Volume (30 Days)
- ZURA 367.0K
- BDL 960.0
- Earning Date
- ZURA 08-14-2025
- BDL 08-12-2025
- Dividend Yield
- ZURA N/A
- BDL 1.90%
- EPS Growth
- ZURA N/A
- BDL 41.91
- EPS
- ZURA N/A
- BDL 2.32
- Revenue
- ZURA N/A
- BDL $201,851,000.00
- Revenue This Year
- ZURA N/A
- BDL N/A
- Revenue Next Year
- ZURA N/A
- BDL N/A
- P/E Ratio
- ZURA N/A
- BDL $12.69
- Revenue Growth
- ZURA N/A
- BDL 8.84
- 52 Week Low
- ZURA $0.97
- BDL $22.61
- 52 Week High
- ZURA $5.07
- BDL $35.98
- Technical
- Relative Strength Index (RSI)
- ZURA 65.78
- BDL 37.07
- Support Level
- ZURA $1.44
- BDL $30.44
- Resistance Level
- ZURA $2.09
- BDL $31.34
- Average True Range (ATR)
- ZURA 0.14
- BDL 0.19
- MACD
- ZURA 0.03
- BDL -0.22
- Stochastic Oscillator
- ZURA 78.31
- BDL 2.94
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.